|
||||||||||||||||
HUM-MOLGEN -> Events -> Meetings and Conferences | ||||||||||||||||
DRUG DISCOVERY TECHNOLOGY 2001-Europe | ||||||||||||||||
January 03, 2001 | ||||||||||||||||
IBC Life Sciences, Messe Stuttgart International, Stuttgart, Germany 23 – 26 April 2001 This congress is now the premier focus in Europe for scientists and managers interested in all aspects of drug discovery. Participants span the range from fledgling biotechs to major pharma, and our blend of formal and informal sessions is intended to stimulate synergistic interactions throughout the conference. With over 55 top level speakers, 80 exhibitors and more than 850 participants, Drug Discovery Technology 2001 provides an unparalleled opportunity to hear and discuss the major strategic, technology and partnering challenges that face the biopharmaceutical industry over the next decade. |
||||||||||||||||
Organized by: | IBC Life Sciences | |||||||||||||||
Invited Speakers: | We are pleased to announce the following Keynote Presentations: * Robert Atwater, Director, NASDAQ Europe, UK * Crispin Kirkman, Chief Executive, BIA, UK * Dr Alfredo Aguilar-Romanillos, Head of the Cell Factory, Research Directorate-General, European Commission, Belgium * Dr Peter S. Ringrose, President, Bristol Myers Squibb, USA * Dr Tom Wilkie, Advisor in Bioethics, The Wellcome Trust, UK |
|||||||||||||||
Deadline for Abstracts: | ||||||||||||||||
Registration: | ||||||||||||||||
E-mail: | ddtinfo@informa.com | |||||||||||||||
Posted by: | C Marshall | |||||||||||||||
Host: | gatekeeper.ibcuk.co.uk | |||||||||||||||
|
||||||||||||||||
Generated by meetings and positions 5.0 by Kai Garlipp |